TP53 and colorectal carcinoma: To assess the functional role of ETBF in modulating molecular subtype identity in colorectal cancer, we used PDOs harboring mutations in APC, KRAS, and TP53, which were classified as CMS2 under standard organoid culture conditions but originated from a CMS4 CRC tissue (Figure S3A).